RESEARCH TRIANGLE PARK, N.C., May 7 /PRNewswire/ -- Quintiles Transnational Corp. today announced that it has signed an agreement to acquire Eidetics, a privately held decision-analytics and market research consulting firm located in Boston as part of its expanding Quintiles Consulting business.
The acquisition of Eidetics will strengthen Quintiles’ core consulting offerings in the areas of product development, commercialization and market access. Quintiles is expanding its consulting practices to help its pharmaceutical, biotech and medical device clients navigate the complex business environment.
“The addition of Eidetics to our Quintiles Consulting business will further strengthen our ability to provide our clients with distinctive, data-driven, strategic solutions to their toughest challenges throughout the product lifecycle,” said Jay Norman, President, Quintiles Consulting.
Eidetics has provided research-based market insights and data analytics to support business decision making in drug development and commercialization for the past 20 years and counts among its repeat clients 18 of the top 20 pharmaceutical companies.
“We are looking forward to welcoming the Eidetics team to Quintiles Consulting,” Norman said. “They have earned an enviable reputation for strong research and analytics expertise and outstanding client service. Together, we will offer industry-leading strategic consulting, powered by life sciences expertise, operational insights and data analytics.”
“We are excited about the opportunity to become part of the Quintiles organization,” said Jim Kirk, Partner, Eidetics. “We believe that joining Quintiles Consulting will build upon the past success of Eidetics’ business, while providing our clients enhanced clinical, patient and provider data, greater therapeutic depth and access to global resources.”
The transaction is contingent upon the completion of certain conditions of the purchase agreement.
About Quintiles Consulting
Quintiles Consulting works with pharmaceutical, biotech and medical device companies to maximize potential and minimize risk from discovery through development and commercialization by providing expert strategic, operational and technical advice. Building on the global reach and expertise of Quintiles Transnational, Quintiles Consulting practice areas include Product Development and Commercialization, Regulatory and Quality, and Market Access. Quintiles Consulting have full-time consultants based across the U.S. and Europe to serve its global clients. For more information, please visit www.quintiles.com/consulting .
About Quintiles
Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, strategic partnering and commercialization for the pharmaceutical, biotechnology and medical device industries. With more than 20,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company’s Web site at www.quintiles.com .
CONTACT: Mari Mansfield, +1-919-998-2639, +1-919-259-3298 (mobile),
mari.mansfield@quintiles.com, or Greg Connors, Investor Relations,
+1-919-998-2000, greg.connors@quintiles.com, both of Quintiles
Transnational Corp.
Web site: http://www.quintiles.com/
http://www.qtrn.com/
http://www.quintiles.com/consulting/
